Buysiders said they are hoping Credit Suisse First Boston and Bank of America will increase the $175 million "B" tranche on the $425 million credit launched for healthcare concern DaVita, Inc. two weeks ago. Buysiders said the "B" is oversubscribed as a result of a well structured credit and desire by buysiders to up their allocations to the sector. A buysider noted that the $250 million pro rata continues to struggle in the face of a tough pro rata market while the "B" blew out and the bond market, also hot for the sector, is reportedly offering a coupon of roughly 9 1/4% on the notes. Richard Whitney, cfo, was not available for comment by press time. Credit Suisse First Boston and Bank of America did not return calls.
Buysiders Look For More 'B' On DaVita Deal